Lalit Kumar is an Indian oncologist, known to have contributed to the development of low cost medical facilities in Delhi.
[4] He completed his higher studies (DM) at the Adyar Cancer Institute, Chennai and followed it up with a post doctoral fellowship at the Royal Postgraduate Medical School of the Hammersmith Hospital, London.
During his tenure at the AIIMS, Kumar is known to have developed cost effective treatment protocols for sustained bone marrow and stem cell transplantations.
[1][4] Kumar is a member of the Indo British Health Initiative (IBHI),[7] a foundation promoting scientific collaboration on healthcare between the UK and India.
[9] He is also a member of the Expert Committee to examine the Serious Adverse Events (SAE) of deaths occurring during clinical trials.